PCRX
Pacira BioSciences Inc

1,572
Mkt Cap
$883.66M
Volume
1.06M
52W High
$27.64
52W Low
$18.80
PE Ratio
47.57
PCRX Fundamentals
Price
$21.22
Prev Close
$20.54
Open
$20.53
50D MA
$23.69
Beta
0.38
Avg. Volume
1.07M
EPS (Annual)
-$2.15
P/B
1.25
Rev/Employee
$887,298.73
Loading...
Loading...
News
all
press releases
Great Lakes Advisors LLC Decreases Stake in Pacira BioSciences, Inc. $PCRX
Great Lakes Advisors LLC lessened its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 51.3% in the third quarter, according to the company in its most recent filing with...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Gagnon Securities LLC Grows Stock Holdings in Pacira BioSciences, Inc. $PCRX
Gagnon Securities LLC boosted its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 22.1% in the third quarter, according to the company in its most recent 13F filing with...
MarketBeat·4d ago
News Placeholder
Pacira BioSciences, Inc. (NASDAQ:PCRX) Given Consensus Recommendation of "Hold" by Analysts
Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Get Free Report) have been given a consensus rating of "Hold" by the six analysts that are currently covering the company, MarketBeat reports. One...
MarketBeat·5d ago
News Placeholder
Pacira (PCRX) is an Incredible Growth Stock: 3 Reasons Why
Pacira (PCRX) could produce exceptional returns because of its solid growth attributes.
Zacks·6d ago
News Placeholder
Will Pacira (PCRX) Beat Estimates Again in Its Next Earnings Report?
Pacira (PCRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks·6d ago
News Placeholder
Pacira BioSciences (NASDAQ:PCRX) Hits New 52-Week Low - Time to Sell?
Pacira BioSciences (NASDAQ:PCRX) Reaches New 12-Month Low - Time to Sell...
MarketBeat·17d ago
News Placeholder
Do Options Traders Know Something About Pacira BioSciences Stock We Don't?
Investors need to pay close attention to PCRX stock based on the movements in the options market lately.
Zacks·18d ago
News Placeholder
Pacira BioSciences (NASDAQ:PCRX) Shares Down 6.9% - What's Next?
Pacira BioSciences (NASDAQ:PCRX) Stock Price Down 6.9% - Time to Sell...
MarketBeat·18d ago
News Placeholder
PCRX, LG Chem Partner to Expand Exparel Reach Across the Asia-Pacific
Pacira BioSciences teams up with LG Chem to expand Exparel across Asia-Pacific, unlocking royalties and new revenue channels to support international growth.
Zacks·19d ago
News Placeholder
PCRX Stock Down 10% as Preliminary Q4 Revenues Miss Estimates
Pacira BioSciences stock slides nearly 10% after preliminary Q4 revenues of $196.9 million miss estimates, despite Exparel sales topping forecasts.
Zacks·21d ago
<
1
2
...
>

Latest PCRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.